Company registration number 921566 (England and Wales)
Charity registration number 255249 (England and Wales)
BRITAIN-NEPAL MEDICAL TRUST
ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
BRITAIN-NEPAL MEDICAL TRUST
LEGAL AND ADMINISTRATIVE INFORMATION
Trustees
Dr G M C Holdsworth
Dr R P Dhital
Mr J W Mecaskey
Dr J M V Payne
Dr A Ramsay
Dr R Fryatt
Mrs JE Beglin
(Appointed 25 March 2025)
Secretary
Dr M Maidrag
Charity number
255249
Company number
921566
Principal address
Lonsdale Gate, Lonsdale Gardens
Lonsdale Gardens
Tunbridge Wells
Kent
TN1 1NU
Registered office
Lonsdale Gate, Lonsdale Gardens
Tunbridge Wells
Kent
TN1 1NU
Independent examiner
J P van der Merwe ACA
Foot Davson Ltd
Lonsdale Gate, Lonsdale Gardens
Tunbridge Wells
Kent
TN1 1NU
BRITAIN-NEPAL MEDICAL TRUST
CONTENTS
Page
Trustees' report
1 - 2
Statement of trustees' responsibilities
3
Independent examiner's report
4
Statement of financial activities
5
Summary income and expenditure account
6
Balance sheet
7
Notes to the financial statements
8 - 16
BRITAIN-NEPAL MEDICAL TRUST
TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 1 -

The trustees present their annual report and financial statements for the year ended 31 December 2025.

The financial statements have been prepared in accordance with the accounting policies set out in note 1 to the financial statements and comply with the charity's governing document, the Companies Act 2006, FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Charities SORP "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)".

Objectives and activities

The charitable purpose of the Britain-Nepal Medical Trust (BNMT) is to improve the health and livelihoods of marginalised and conflict-affected communities, particularly those living in remote and rural areas of Nepal.

We pursue this aim goal in partnership with Birat-Nepal Medical Trust (BNMT Nepal), an independent local NGO established to advance BNMT’s charitable purpose in Nepal. Together, we work to strengthen local partners—including community groups, NGOs and health workers—empower communities to secure better access to quality health services, and advocate for those whose needs are not adequately met. We also support innovation, generate evidence and promote the adoption and mainstreaming of interventions that have demonstrated their effectiveness.

In determining the activities undertaken by the charity, the Trustees have had due regard to the guidance issued by the Charity Commission on public benefit.

Achievements and performance

BNMT’s support for national health efforts in Nepal is delivered exclusively through BNMT Nepal. Our work is organised around six interconnected priorities: accelerating the elimination of infectious diseases; generating and mobilising evidence to inform policy; improving mental health and reducing stigma; strengthening emergency preparedness and response; strengthening health systems; and building resilient and prosperous communities in a changing climate.

BNMT provides both financial and technical support to BNMT Nepal as part of our long-term commitment to sustainable, locally led impact. This partnership reflects our belief that lasting improvements in health are best achieved by strengthening Nepal’s own institutions, communities and capacity to identify and address their health priorities.

BNMT also works closely with other UK-based organisations committed to the health and wellbeing of the Nepali people. Together, we advocate for continued UK Government engagement with and support for Nepal in improving the health and wellbeing of its population.

This role has become increasingly important in the context of substantial recent reductions in global development assistance, including reductions in UK development funding. At a time of growing financial pressure, BNMT remains committed to sustaining effective partnerships, strengthening locally led solutions and ensuring that progress in the health of Nepal’s most disadvantaged communities is not lost.

Financial review

Unrestricted funds showed a deficit for the year of £109,025 (2024: £34,061), and an increase in the value of the investments of £7,861 (2024: £1,165). This gives an overall decrease in unrestricted funds of £101,164 (2024: £32,896), leaving a balance of £156,056 (2024: £257,220).

Restricted funds showed an increase of £2,064 (2024: £55), leaving a restricted balance of £6,044 (2024: £3,980) to be used in later periods.

The Directors aim to hold unrestricted reserves of between 3 and 6 months annual income as working capital. Investments held are medium term and are reviewed two times each year. The Trustees have ethical considerations when making decisions to ensure particularly that healthcare considerations are not compromised. Cash deposits are held at best interest rates commensurate with accessibility for cash flow purposes.

BRITAIN-NEPAL MEDICAL TRUST
TRUSTEES' REPORT (CONTINUED)(INCLUDING DIRECTORS' REPORT)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 2 -

The trustees have assessed the major risks to which the charity is exposed, and are satisfied that systems are in place to mitigate exposure to the major risks.

The Directors have a risk management strategy which comprises the maintenance of a detailed risk register which is reviewed annually. Interim reviews have also been carried out to assess and adjust policies as necessary to take account of changing security concerns in Nepal and variations to emergency procedures.

Structure, governance and management

The charity was established as a charitable company limited by guarantee on 7th November 1967 (company number 921566). The company is registered with the Charity Commission (charity number 255249).

The Board of Trustees meets in the UK. The Charity's programme of activities is carried out in Nepal by BNMT Nepal, a not for profit organisation, registered in Nepal. It employs staff and works with partners to deliver the Charity's objectives.

The trustees, who are also the directors for the purpose of company law, and who served during the year and up to the date of signature of the financial statements were:

Dr G M C Holdsworth
Dr R P Dhital
Mr J W Mecaskey
Dr J M V Payne
Dr A Ramsay
Dr R Fryatt
Mrs S Barton
(Resigned 22 July 2026)
Mrs JE Beglin
(Appointed 25 March 2025)

New candidates for the Board are proposed by existing Trustees. Candidates receive written advice on the roles and responsibilities of Trustees and are invited to attend a Board meeting. Thereafter the Chair of the Board and the candidate exchange views and if appropriate the incoming Trustee is proposed, seconded and elected at the next Board meeting.

None of the trustees has any beneficial interest in the company. All of the trustees are members of the company and guarantee to contribute £1 in the event of a winding up.

The Board of Trustees is the final decision-making body. The Board is advised by a Finance & General Purposes Committee, composed of Trustees, the Country Director, the Company Secretary and Financial Adviser.

The trustees' r eport was approved by the Board of Trustees.

Mr J W Mecaskey
Trustee
Dated: 19 August 2026
BRITAIN-NEPAL MEDICAL TRUST
STATEMENT OF TRUSTEES' RESPONSIBILITIES
FOR THE YEAR ENDED 31 DECEMBER 2025
- 3 -

The trustees, who are also the directors of Britain-Nepal Medical Trust for the purpose of company law, are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charity and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that year.

In preparing these financial statements, the trustees are required to:

- select suitable accounting policies and then apply them consistently;

- observe the methods and principles in the Charities SORP;

- make judgements and estimates that are reasonable and prudent;

- state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and

- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in operation.

The trustees are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

BRITAIN-NEPAL MEDICAL TRUST
INDEPENDENT EXAMINER'S REPORT
TO THE TRUSTEES OF BRITAIN-NEPAL MEDICAL TRUST
- 4 -

I report to the trustees on my examination of the financial statements of Britain-Nepal Medical Trust (the charity) for the year ended 31 December 2025.

Responsibilities and basis of report

As the trustees of the charity (and also its directors for the purposes of company law), you are responsible for the preparation of the financial statements in accordance with the requirements of the Companies Act 2006.

Having satisfied myself that the financial statements of the charity are not required to be audited under Part 16 of the Companies Act 2006 and are eligible for independent examination, I report in respect of my examination of the charity’s financial statements carried out under section 145 of the Charities Act 2011. In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the Charities Act 2011.

Independent examiner's statement

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:

1

accounting records were not kept in respect of the charity as required by section 386 of the Companies Act 2006.

2

the financial statements do not accord with those records; or

3

the financial statements do not comply with the accounting requirements of section 396 of the Companies Act 2006 other than any requirement that the financial statements give a true and fair view, which is not a matter considered as part of an independent examination; or

4

the financial statements have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities applicable to charities preparing their financial statements in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102).

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached.

J P van der Merwe ACA
For and on behalf of
Lonsdale Gate
Lonsdale Gardens
Foot Davson Ltd
Tunbridge Wells
Chartered Accountants
Kent
TN1 1NU
Dated: 20 August 2026
BRITAIN-NEPAL MEDICAL TRUST
STATEMENT OF FINANCIAL ACTIVITIES
INCLUDING INCOME AND EXPENDITURE ACCOUNT
FOR THE YEAR ENDED 31 DECEMBER 2025
- 5 -
Unrestricted
Restricted
Total
Total
funds
funds
2025
2024
Notes
£
£
£
£
Income from:
Donations and legacies
2
81,885
5,799
87,684
60,779

Investment s

3
1,170
-
1,170
2,139
Other income
4
11,788
-
11,788
25
Total income
94,843
5,799
100,642
62,943
Expenditure on:

R aising funds

5
19,523
-
19,523
11,034
Charitable activities
6
184,345
3,735
188,080
85,915
Total expenditure
203,868
3,735
207,603
96,949
(109,025)
2,064
(106,961)
(34,006)
Net (losses)/ gains on investments
10
7,861
-
7,861
1,165
Net movement in funds
(101,164)
2,064
(99,100)
(32,841)
Fund balances at 1 January 2025
257,220
3,980
261,200
294,041
Fund balances at 31 December 2025
156,056
6,044
162,100
261,200

The statement of financial activities includes all gains and losses recognised in the year.

The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.

The statement of financial activities also complies with the requirements for an income and expenditure account under the Companies Act 2006.
BRITAIN-NEPAL MEDICAL TRUST
SUMMARY INCOME AND EXPENDITURE ACCOUNT
FOR THE YEAR ENDED 31 DECEMBER 2025
- 6 -
All income funds
2025
2024
£
£
Gross income
100,642
62,943
Gains on investments
7,861
1,165
Total income in the reporting period
108,503
64,108
Total expenditure from income funds
207,603
96,949
Net expenditure for the year
(99,100)
(32,841)
BRITAIN-NEPAL MEDICAL TRUST
BALANCE SHEET
AS AT 31 DECEMBER 2025
31 December 2025
- 7 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
11
1
1
Current assets
Debtors
13
15,820
1,844
Investments
99,720
102,972
Cash at bank and in hand
51,695
161,393
167,235
266,209
Creditors: amounts falling due within one year
14
(5,136)
(5,010)
Net current assets
162,099
261,199
Total assets less current liabilities
162,100
261,200
The funds of the charity
Restricted income funds
17
6,044
3,980
Unrestricted funds
16
156,056
257,220
162,100
261,200

The charitable company is entitled to the exemption from the audit requirement contained in section 477 of the Companies Act 2006, for the year ended 31 December 2025.

The directors/trustees acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the trustees on 19 August 2026
Mr J W Mecaskey
Mrs JE Beglin
Trustee
Trustee
BRITAIN-NEPAL MEDICAL TRUST
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 8 -
1
Accounting policies
Company information

Britain-Nepal Medical Trust was established as a charitable company limited by guarantee on 7th November 1967 (company number 921566). The company is registered with the Charity Commission (charity number 255249).

1.1
Accounting convention

The financial statements have been prepared in accordance with the charity's governing document, the Companies Act 2006, FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the Charities SORP "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)" (effective 1 January 2019). The charity is a Public Benefit Entity as defined by FRS 102.

The charity has taken advantage of the provisions in the SORP for charities not to prepare a Statement of Cash Flows.

The financial statements are prepared in sterling, which is the functional currency of the charity. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

At the time of approving the financial statements, the trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Charitable funds

Unrestricted funds are available for use at the discretion of the trustees in furtherance of their charitable objectives.

Restricted funds are subject to specific conditions by donors or grantors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the financial statements.

1.4
Income
Income is recognised when the charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.

Cash donations are recognised on receipt. Other donations are recognised once the charity has been notified of the donation, unless performance conditions require deferral of the amount. Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation.

Legacies are recognised on receipt or otherwise if the charity has been notified of an impending distribution, the amount is known, and receipt is expected. If the amount is not known, the legacy is treated as a contingent asset.
1.5
Expenditure and irrecoverable VAT

Expenditure is recognised as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that settlement will be required and the amount of the obligation can be measured reliably.

BRITAIN-NEPAL MEDICAL TRUST
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 9 -

All expenditure is accounted for on an accruals basis. All expenditure including support costs and governance costs are allocated or apportioned to the applicable expenditure headings.

Irrecoverable VAT is charged against the expenditure heading for which it was incurred.

Grants payable are payments to charities in Nepal, which are charged in the year when the grant is awarded by the Trustees.

1.6
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers
25% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the statement of financial activities.

1.7
Impairment of fixed assets

At each reporting end date, the charity reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

1.8
Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.9
Financial instruments

The trust only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of current asset investments which are subsequently measured at fair value with any gains or losses arising on remeasurement recognised in profit or loss.

BRITAIN-NEPAL MEDICAL TRUST
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 10 -
2
Donations and legacies
Unrestricted
Restricted
Total
Total
funds
funds
2025
2024
£
£
£
£
Donations and gifts
26,885
5,799
32,684
26,458
Legacies receivable
55,000
-
55,000
34,321
81,885
5,799
87,684
60,779
Unrestricted donations
81,885
58,189
Restricted donations
5,799
2,590
87,684
60,779
Donations and gifts
Yeung Drung
-
420
420
420
Scholarship and specific Nepali family support
-
5,379
5,379
2,170
Gift aided and other donations
26,885
-
26,885
23,868
26,885
5,799
32,684
26,458

3
Investment income
Unrestricted
Total
funds
2025
2024
£
£
Income from listed investments
217
245
Interest receivable
953
1,894
1,170
2,139

All investment income earned, during both this financial reporting period and the previous reporting period, was of an unrestricted nature.

4
Other income
2025
2024
£
£
Other income
11,788
25
BRITAIN-NEPAL MEDICAL TRUST
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
4
Other income
(Continued)
- 11 -

All other income received, during both this financial reporting period and the previous reporting period, was of an unrestricted nature.

5

R aising funds

Unrestricted
Total
funds
2024
£
£
Cost of generating donations and legacies:
Publicity and fundraising
10,248
1,585
Annual Report
4,088
3,998

Accountancy

1,072
926
Consultants and professional services
978
1,493
Staff salaries
2,906
2,734
Office expenses
231
298
19,523
11,034
BRITAIN-NEPAL MEDICAL TRUST
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 12 -
6
Charitable activities

Programme costs

Support costs
Gov'nce costs
Total
2024
£
£
£
£
£
Staff costs
-
1,938
4,844
6,782
6,380
Office expenses
-
399
396
795
841
Travel and Trustees expenses
-
4,009
-
4,009
957
Consultants and professional services
-
244
3,666
3,910
5,970
Independent examination fees
-
-
4,022
4,022
3,474
Accountancy
-
268
-
268
232
-
6,858
12,928
19,786
17,854
Grants payable (see note 7)
168,294
-
-
168,294
68,061
Total
168,294
6,858
12,928
188,080
85,915
Analysis by fund
Unrestricted funds
164,559
6,858
12,928
184,345
Restricted funds
3,735
-
-
3,735
168,294
6,858
12,928
188,080
For the year ended 31 December 2024
Unrestricted funds
65,526
3,784
14,070
83,380
Restricted funds
2,535
-
-
2,535
68,061
3,784
14,070
85,915
7
Grants payable
2025
2024
£
£
Grants to Birat Nepal Medical Trust
164,559
65,526
Grants of restricted funds (Note 17)
3,735
2,535
168,294
68,061
8
Trustees

None of the trustees (or any persons connected with them) received any remuneration during the year, but a total of £4,009 was reimbursed for travelling expenses (2024- total of £957).

BRITAIN-NEPAL MEDICAL TRUST
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 13 -
9
Employees
Number of employees

The average monthly number of employees during the year was:

2025
2024
Number
Number
1
1
Employment costs
2025
2024
£
£
Wages and salaries
9,688
9,114
10
Net gains/(losses) on investments
2025
2024
£
£
Revaluation of investments
7,004
1,165
Gain/loss on sale of investments
857
-
7,861
1,165

All gains/(losses) on investments, during both this financial reporting period and the previous reporting period, related to unrestricted funds.

11
Tangible fixed assets
Computers
£
Cost
At 1 January 2025
1,743
At 31 December 2025
1,743
Depreciation and impairment
At 1 January 2025
1,742
At 31 December 2025
1,742
Carrying amount
At 31 December 2025
1
At 31 December 2024
1
BRITAIN-NEPAL MEDICAL TRUST
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 14 -
12
Financial instruments
2025
2024
£
£
Carrying amount of financial assets
Instruments measured at fair value through profit or loss
99,720
102,972

Current asset investments are initially recognised at cost and are subsequently remeasured at fair value, being the quoted market price, with any gains or losses arising on remeasurement recognised in the SOFA.

At the year end the investments held had an original cost value of £5,514 (2024: £8,706) and a fair value (quoted market price) of £99,720 (2024: £102,972).

During the year the charitable company disposed of an investment for proceeds of £11,113 and a realised gain of £857. In 2026 the charitable company realised its remaining two investments. In future, surplus cash will be held in high interest deposit accounts.

13
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
15,820
1,844
14
Creditors: amounts falling due within one year
2025
2024
£
£
Other creditors
137
410
Accruals and deferred income
4,999
4,600
5,136
5,010

15
Analysis of net assets between funds
Unrestricted funds

Restricted funds

Total
£
£
£
Fund balances at 31 December 2025 are represented by:
Tangible fixed assets
1
-
1
Current assets/(liabilities)
156,055
6,044
162,099
156,056
6,044
162,100
BRITAIN-NEPAL MEDICAL TRUST
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 15 -
16
Unrestricted funds

The unrestricted funds of the charity compri se the unexpended balances of donations and grants which are not subject to specific conditions by donors and grantors as to how they may be use d. The se include designated funds which have been set aside out of unrestricted funds by the trustees for specific purposes.

At 1 January 2025
Incoming resources
Resources expended
Gains and losses
At 31 December 2025
£
£
£
£
£
General funds
257,220
94,843
(203,868)
7,861
156,056
Previous year:
At 1 January 2024
Incoming resources
Resources expended
Gains and losses
At 31 December 2024
£
£
£
£
£
General funds
290,116
60,353
(94,414)
1,165
257,220
17
Restricted funds

The income funds of the charity include restricted funds comprising the following unexpended balances of donations and grants held on trust for specific purposes:

Movement in funds
Balance at 1 January 2025

Incoming resources

Resources expended
Balance at 31 December 2025
£
£
£
£
Yeung Drung
315
420
(735)
-
Scholarship and specific Nepali family support
3,665
5,379
(3,000)
6,044
3,980
5,799
(3,735)
6,044
BRITAIN-NEPAL MEDICAL TRUST
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 16 -
18
Funds held as administrator
2025
2024
£
£
Funds held at 31st December:
PDP Funders Group
35,786
5,853
35,786
5,853
The charity administers the above funds. These funds are not charity assets and are therefore
not included in the charity's financial statements.
2025-12-31 2025-01-01 CCH Accounts Production 2026.200 false false false CCH Software 921566 2025-01-01 2025-12-31 921566 bus:Director1 2025-01-01 2025-12-31 921566 bus:Director2 2025-01-01 2025-12-31 921566 bus:Director3 2025-01-01 2025-12-31 921566 bus:Director4 2025-01-01 2025-12-31 921566 bus:Director5 2025-01-01 2025-12-31 921566 bus:Director6 2025-01-01 2025-12-31 921566 bus:Director8 2025-01-01 2025-12-31 921566 bus:CompanySecretary1 2025-01-01 2025-12-31 921566 bus:Director7 2025-01-01 2025-12-31 921566 2025-12-31 921566 2024-12-31 921566 2024-01-01 2024-12-31 921566 bus:FRS102 2025-01-01 2025-12-31 921566 char:IndependentExaminationCharity 2025-01-01 2025-12-31 921566 bus:FullAccounts 2025-01-01 2025-12-31 xbrli:pure xbrli:shares iso4217:GBP